Different scientific tests on the use of BoNT within the administration of different discomfort Diseases are listed in Table three. On August two, 2010, the US FDA announced the approval of incobotulinumtoxinA (Xeomin®) for the treatment of adults with cervical dystonia, to reduce the severity of abnormal head place and neck ache in the two